# Tellihealth

> Tellihealth combines connected monitoring devices, its Evelyn software platform, and clinical care teams to help US hospitals and physician practices manage patients between appointments. It was formed through the 2024 combination of Accuhealth and Signallamp Health, bringing remote patient monitoring and chronic care management into one service business.

- **Founded:** 2015
- **Headquarters:** Houston, United States
- **Founders:** Drew Kearney (Co-founder of predecessor Signallamp Health; named Tellihealth Chief Strategy Officer in the merger FAQ), Andrew Goldberg (Co-founder of predecessor Signallamp Health), Stephen Samson (Co-founder of predecessor Accuhealth)
- **Products:** accuRPM, signalCCM, Evelyn, Tellihealth Devices, accuCCM
- **Notable:** July 2024 merger announcement: more than 300 client organizations across 48 states., Company reported rank 312 and 244% revenue growth in the 2025 Deloitte Technology Fast 500., Company announced the 2026 MedTech Breakthrough Virtual Care Innovation Award.

## Products & services

- **accuRPM** — Managed remote patient monitoring combining connected devices, clinical monitoring, alerts, and EHR integration.
- **signalCCM** — Chronic care management with patient outreach, care coordination, medication support, and documentation.
- **Evelyn** — Remote care software platform; September 2025 enhancements included a caller dashboard, assessment templates, patient app, and wellness game.
- **Tellihealth Devices** — Cellular medical devices including blood pressure monitors, pulse oximeters, thermometers, and other monitoring hardware.
- **accuCCM** — Additional chronic care management service named in recent company announcements; detailed positioning is not separately established in the reviewed materials.

## Achievements

- July 2024 merger announcement: more than 300 client organizations across 48 states.
- Company reported rank 312 and 244% revenue growth in the 2025 Deloitte Technology Fast 500.
- Company announced the 2026 MedTech Breakthrough Virtual Care Innovation Award.
- May 2025 company release reported mean systolic reductions of 9 mmHg at three months and 11 mmHg at one year among adherent patients starting 2024 with stage 2 hypertension; not presented here as a controlled trial.

## Latest updates

- **2026-05** — Announced the Virtual Care Innovation Award from MedTech Breakthrough; release dateline May 7, page published May 28.
- **2026-03** — Named Kim Johnson, DNP, Vice President of Customer Success.
- **2025-11** — Announced its 2025 Deloitte Technology Fast 500 ranking.
- **2025-09** — Announced Evelyn enhancements including caller information, assessment templates, and patient engagement tools.

## Links

- Website: https://tellihealth.com/
- LinkedIn: https://www.linkedin.com/company/telli-health/
- Twitter/X: https://x.com/accuhealth15
- Instagram: https://www.instagram.com/tellihealth_remote_care/
- Facebook: https://www.facebook.com/Tellihealth

---

Profile page: https://yespress.io/tellihealth
Published by YesPress — https://yespress.io
Last updated: 2026-10-23